phenytoin sodium 100mg capsules
de pharmaceuticals - phenytoin sodium - oral capsule - 100mg
phenytoin sodium 100mg capsules
pharmaram ltd - phenytoin sodium - oral capsule - 100mg
phenytoin sodium 100mg tablets
phenytoin sodium - tablet - each tablet contains phenytoin sodium 100mg - phenytoin
phenytoine 250mg/5ml injection
phenytoine 250mg/5ml - injection - phenytoine 250mg/5ml - antibacterials for systemic use
fosphenytoin sodium injection solution
fresenius kabi usa, llc - fosphenytoin sodium (unii: 7vlr55452z) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 50 mg in 1 ml
fosphenytoin sodium- fosphenytoin sodium injection
wockhardt usa llc. - fosphenytoin sodium (unii: 7vlr55452z) (phenytoin - unii:6158tkw0c5) - fosphenytoin sodium injection, usp is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery. fosphenytoin sodium injection, usp can also be substituted, short-term, for oral phenytoin. fosphenytoin sodium injection, usp should be used only when oral phenytoin administration is not possible [see dosage and administration (2.4) and warnings and precautions (5.2)] . fosphenytoin sodium injection is contraindicated in patients with: - a history of hypersensitivity to fosphenytoin sodium injection or its inactive ingredients, or to phenytoin or other hydantoins [see warnings and precautions (5.6)] . reactions have included angioedema. - sinus bradycardia, sino-atrial block, second and third degree a-v block, or adams-stokes syndrome because of the effect of parenteral phenytoin or fosph
phenytoin sodium capsule extended release
mckesson contract packaging - phenytoin sodium (unii: 4182431bjh) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 100 mg
phenytek- extended phenytoin sodium capsule, extended release phenytek- phenytoin sodium capsule, extended release
mylan pharmaceuticals inc. - phenytoin sodium (unii: 4182431bjh) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 200 mg - phenytek® capsules (extended phenytoin sodium capsules) are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. phenytek® capsules are contraindicated in patients with: there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as phenytek® capsules, during pregnancy. physicians are advised to recommend that pregnant patients taking phenytek® capsules enroll in the north american antiepileptic drug (naaed) pregnancy registry. this can be done by calling the tollfree number 1-888-233-2334, and must be done by patients themselves. information on the registry can also be found at the website http://www.aedpregnancyregistry.org/ in humans, prenatal exposure to phenytoin may increase the risks for congenital malformations and other adverse developmental outcomes. prenatal phenytoin exposure is associated with an incre
extended phenytoin sodium capsule
tya pharmaceuticals - phenytoin sodium (unii: 4182431bjh) (phenytoin - unii:6158tkw0c5) - phenytoin sodium 100 mg - extended phenytoin sodium capsules, usp are indicated for the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. phenytoin serum level determinations may be necessary for optimal dosage adjustments (see and sections). dosage and administrationclinical pharmacology phenytoin is contraindicated in those patients who are hypersensitive to phenytoin or other hydantoins.
phenytoin suspension
actavis pharma, inc. - phenytoin (unii: 6158tkw0c5) (phenytoin - unii:6158tkw0c5) - phenytoin 125 mg in 5 ml